Exagen Q2 FY26 net loss narrows 28% to $3.2 million; revenue rises 16% to $19.9 million
Reuters2026/08/04 12:09- Exagen posted Q2 revenue of $ USD 19.9 million, up 16% from Q2 2025, as it set record revenue and test volume.
- GAAP net loss narrowed to $ USD 3.2 million; GAAP operating loss tightened to $ USD 1.7 million.
- Non-GAAP adjusted EBITDA loss shrank to $ USD 114,000 from $ USD 1.7 million a year earlier.
- Trailing-twelve-month average selling price rose 4% to $ USD 446 per test; AVISE CTD test volume climbed 11% year over year.
- Raised full-year 2026 revenue guidance to $ USD 72 million-$ USD 75 million; ended the quarter with about $ USD 25 million in cash.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Storage Giant Offers Huge Bonuses Again: Micron Awards Up to 68 Months’ Bonus
Micron Technology has announced record-breaking bonuses for its employees in Taiwan, ranging from 35 to 68 months’ salary, with a minimum cash compensation of 1.7 million New Taiwan dollars. However, the Taoyuan union, representing about two-thirds of Micron’s workers in Taiwan, has refused to accept the offer, insisting that 15% of operating profits be included in the bonus distribution and maintaining the threat of a strike.
Dogecoin ETF Closure Sets October Exit for Bitwise BWOW Holders
Crypto prices
More
